Patents by Inventor Jay Evans

Jay Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260137775
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
    Type: Application
    Filed: November 18, 2025
    Publication date: May 21, 2026
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Patent number: 12496340
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmnune disorders.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: December 16, 2025
    Assignee: THE UNIVERSITY OF MONTANA
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Patent number: 12319709
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Grant
    Filed: February 9, 2024
    Date of Patent: June 3, 2025
    Assignee: University of Montana
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Publication number: 20240325517
    Abstract: Multivalent conjugates and conjugate compositions of peptides derived from the CoaB coat protein of Pseudomonas aeruginosa filamentous (Pf) bacteriophage and conjugates adjuvanted with a TLR 4 and/or TLR 7/8 agonist induce and/or enhance an immune response toward Pseudomonas aeruginosa filamentous (Pf) bacteriophage. The conjugates, compositions, and vaccines have utility to reduce, prevent and/or ameliorate the adverse effect of Pseudomonas aeruginosa infection, such as biofilm formation.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 3, 2024
    Inventors: Patrick Secor, Jay Evans, David Burkhart
  • Publication number: 20240309037
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Application
    Filed: February 9, 2024
    Publication date: September 19, 2024
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Patent number: 11964014
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: April 23, 2024
    Assignee: THE UNIVERSITY OF MONTANA
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Patent number: 11912736
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: February 27, 2024
    Assignee: THE UNIVERSITY OF MONTANA
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Publication number: 20240024469
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
    Type: Application
    Filed: August 8, 2023
    Publication date: January 25, 2024
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Publication number: 20230310438
    Abstract: Provided herein are TLR7/8 agonists to enhance immune responses or for use as adjuvants in fentanyl vaccines in opioid-using individuals.
    Type: Application
    Filed: October 16, 2020
    Publication date: October 5, 2023
    Applicants: Children's Medical Center Corporation, the University of Montana, Regents of the University of Minnesota
    Inventors: David J. Dowling, Ofer Levy, Dheeraj Soni, Sharon Levy, Jay Evans, Marco Pravetoni, David Burkhart, Shannon Miller
  • Patent number: 11572381
    Abstract: Disclosed herein are immunogenic trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: February 7, 2023
    Assignee: The University of Montana
    Inventors: David Burkhart, Jay Evans, Craig Johnson, Kendal T. Ryter, Alyson Smith, Walid Abdelwahab Marzouky Abdelwahab
  • Publication number: 20230008024
    Abstract: The present disclosure provides compositions comprising an isolated polysaccharide comprising ?-1,4 linked galactosamine and glucosamine monomers, wherein the amino groups of each of the galactosamine and glucosamine are partially substituted with acetate. The disclosure further provides vaccine, methods of use, and methods of producing the isolated polysaccharide.
    Type: Application
    Filed: December 3, 2020
    Publication date: January 12, 2023
    Inventors: Laura K. JENNINGS, Patrick R. SECOR, Jay EVANS
  • Patent number: 11464854
    Abstract: The methods and compositions described herein relate to methods of immunization or stimulating an immune response, e.g., using agonists of TLR7 and/or TLR8 as antigens. The methods and compositions described herein have particular relevance to use in infants.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: October 11, 2022
    Assignees: Children's Medical Center Corporation, University of Montana
    Inventors: Ofer Levy, David Dowling, Helene Bazin-Lee, David Burkhart, Jay Evans, Alyson Jessica Smith
  • Publication number: 20220241410
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmnune disorders.
    Type: Application
    Filed: May 22, 2020
    Publication date: August 4, 2022
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Publication number: 20220002720
    Abstract: This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.
    Type: Application
    Filed: February 4, 2021
    Publication date: January 6, 2022
    Inventors: Alex INBERG, Mahak KAPOOR, Jay EVANS
  • Publication number: 20210139521
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Application
    Filed: February 21, 2019
    Publication date: May 13, 2021
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Patent number: 10927374
    Abstract: This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: February 23, 2021
    Assignees: Monsanto Technology LLC, Beeologics, Inc., The United States of America, as represented by the Secretary of Agriculture
    Inventors: Alex Inberg, Mahak Kapoor, Jay Evans
  • Publication number: 20200369704
    Abstract: Disclosed herein are immunogenic trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Application
    Filed: March 1, 2019
    Publication date: November 26, 2020
    Inventors: David Burkhart, Jay Evans, Craig Johnson, Kendal T. Ryter, Alyson Smith, Walid Abdelwahab Marzouky Abdelwahab
  • Publication number: 20200108139
    Abstract: The methods and compositions described herein relate to methods of immunization or stimulating an immune response, e.g., using agonists of TLR7 and/or TLR8 as antigens. The methods and compositions described herein have particular relevance to use in infants.
    Type: Application
    Filed: March 23, 2018
    Publication date: April 9, 2020
    Applicants: THE CHILDREN'S MEDICAL CENTER CORPORATION, UNIVERSITY OF MONTANA
    Inventors: Ofer LEVY, David DOWLING, Helene BAZIN-LEE, David BURKHART, Jay EVANS, Alyson Jessica SMITH
  • Patent number: 10415740
    Abstract: A removable motor housing for a plant material trimming device. The removable housing may include a first motor housing connectable to the plant trimming device. The first motor housing may be slidably or pivotably connectable to the plant trimming device. The first motor housing may be operable to receive an output shaft from a first motor in the first housing. The output shaft may be operable to communicate with an input shaft of the plant trimming device. A biasing device may be connectable to the first motor housing and the plant trimming device for biasing the first motor housing into a first position. When the first motor housing is in the first position a substantially constant force is applied between the input shaft of the plant trimming device and the output shaft of the first motor.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: September 17, 2019
    Assignee: Keirton, Inc.
    Inventors: Jay Evans, Aaron McKellar
  • Publication number: 20180371459
    Abstract: This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.
    Type: Application
    Filed: September 7, 2018
    Publication date: December 27, 2018
    Inventors: Alex Inberg, Mahak Kapoor, Jay Evans